– Data add to the growing body of clinical and scientific evidence demonstrating the therapeutic potential of Aramchol, a stearoyl... View Article
Categories for Uncategorized
Galmed Pharmaceuticals Announces Publication in “The Journal of Autoimmunity” for its IND ready, Amilo-5MER, a specific anti-inflammatory compoundAugust 19, 2021 12:00 pm Leave your thoughts
– Amilo-5MER suppresses chronic inflammations in broad spectrum of animal models of inflammatory diseases.
MHRA Agrees with Galmed’s Plan to use Aramchol meglumine in the Randomized Double-blind Placebo-Controlled Part of the Phase 3 ARMOR studyAugust 16, 2021 12:00 pm Leave your thoughts
– MHRA agreement follows similar agreement from the FDA which allows Galmed to proceed with its proposed clinical studies with... View Article